Time-dependent inhibition of PHD2
Isabelle Tcholakov1, Charles E Grimshaw2, Lihong Shi2
1In Vitro Pharmacology, Immunology, Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, U.S.A.
Abstract:
Prolyl hydroxylases (PHDs) down-regulate the level of hypoxia-inducible factors (HIFs) by hydroxylating key proline residues that trigger the degradation of the protein and affect the cell and its ability to respond to hypoxic stress. Several small molecule PHD inhibitors are now in various preclinical and clinical stages for the treatment of anemia. The present study provides a detail kinetic analysis for some of these inhibitors. The data generated in the present study suggest that these compounds are reversible and compete directly with the co-substrate, 2-oxoglutarate (2-OG) for binding at the enzyme active site. Most of these compounds are pan PHD inhibitors and exhibit a time-dependent inhibition (TDI) mechanism due to an extremely slow dissociation rate constant, koff, and a long residence time.
Insights
Small molecule inhibitors targeting prolyl hydroxylases (PHDs) show promise for anemia treatment. These compounds reversibly inhibit PHDs by competing with 2-oxoglutarate, acting as pan PHD inhibitors with long-lasting effects.
Area of Science:
- Biochemistry
- Pharmacology
- Cellular Biology
Background:
- Prolyl hydroxylases (PHDs) regulate hypoxia-inducible factors (HIFs) through proline residue hydroxylation, impacting cellular response to hypoxia.
- PHD inhibitors are under investigation for anemia treatment, with several in clinical trials.
Purpose of the Study:
- To perform detailed kinetic analysis of small molecule PHD inhibitors.
- To elucidate the mechanism of inhibition for these compounds.
Main Methods:
- Enzyme kinetics assays were performed to determine inhibition constants and mechanisms.
- Analysis included determination of co-substrate competition and time-dependent inhibition (TDI).
Main Results:
- The inhibitors were found to be reversible and competitive with 2-oxoglutarate (2-OG) at the enzyme active site.
- Most compounds acted as pan PHD inhibitors, affecting multiple PHD isoforms.
- A time-dependent inhibition (TDI) mechanism was observed, characterized by a slow dissociation rate constant (koff) and long residence time.
Conclusions:
- Small molecule PHD inhibitors exhibit competitive inhibition with 2-OG.
- The observed TDI mechanism suggests prolonged target engagement, potentially beneficial for therapeutic applications.
- These findings provide valuable kinetic insights for the development of PHD inhibitors for anemia.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Negative Regulator Molecules
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle


